These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 2869686)

  • 1. Regulatory controversy surrounding ipecac use and misuse.
    Brushwood DB; Tietze KJ
    Am J Hosp Pharm; 1986 Jan; 43(1):157-61. PubMed ID: 2869686
    [No Abstract]   [Full Text] [Related]  

  • 2. Balance, change, and responsible prescribing: clinicians need updated regulatory policies and the tools to evaluate patients and meet clinical and regulatory obligations!
    Bolen J
    Clin J Pain; 2010 Jan; 26(1):78-9. PubMed ID: 20026958
    [No Abstract]   [Full Text] [Related]  

  • 3. Guiding principles of international and federal laws pertaining to medical use and diversion of controlled substances.
    Joranson DE
    NIDA Res Monogr; 1993; 131():18-34. PubMed ID: 8413529
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulating off-label drug use--rethinking the role of the FDA.
    Stafford RS
    N Engl J Med; 2008 Apr; 358(14):1427-9. PubMed ID: 18385495
    [No Abstract]   [Full Text] [Related]  

  • 5. US court lifts restrictions on some emergency contraceptives.
    McCarthy M
    BMJ; 2013 Jun; 346():f3760. PubMed ID: 23752053
    [No Abstract]   [Full Text] [Related]  

  • 6. No doctor required. The FDA may expand the number of prescription drugs it converts to over-the-counter use.
    Thompson M
    Time; 2000 Jul; 156(3):38. PubMed ID: 11009720
    [No Abstract]   [Full Text] [Related]  

  • 7. A flood of opioids, a rising tide of deaths.
    Okie S
    N Engl J Med; 2010 Nov; 363(21):1981-5. PubMed ID: 21083382
    [No Abstract]   [Full Text] [Related]  

  • 8. ASHP technical assistance bulletin on institutional use of controlled substances.
    Am J Hosp Pharm; 1987 Mar; 44(3):580-9. PubMed ID: 3565417
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonprescription sale of inhaled metaproterenol--déjà vu.
    Hendeles L; Weinberger M
    N Engl J Med; 1984 Jan; 310(3):207-8. PubMed ID: 6690937
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical quackery in Rhode Island: the perspective of state and federal drug control agencies.
    Fairfield PB; Hachadorian C
    R I Med J (1976); 1990 Apr; 73(4):145-7. PubMed ID: 2336519
    [No Abstract]   [Full Text] [Related]  

  • 11. Economic aspects of drug over use.
    Rucker TD
    Med Ann Dist Columbia; 1973 Dec; 42(12):609-14. PubMed ID: 4520521
    [No Abstract]   [Full Text] [Related]  

  • 12. Rave drugs: pharmacological considerations.
    Hornfeldt CS
    AANA J; 2004 Oct; 72(5):334-5; author reply 335. PubMed ID: 15529726
    [No Abstract]   [Full Text] [Related]  

  • 13. From balanced pain care to drug trafficking: the case of Dr. William Hurwitz and the DEA.
    Fishman SM
    Pain Med; 2005; 6(2):162-4. PubMed ID: 15773882
    [No Abstract]   [Full Text] [Related]  

  • 14. New tax law will result in requests for prescriptions for over-the-counter drugs.
    Schulte DJ
    Mich Med; 2011; 110(2):3. PubMed ID: 21510156
    [No Abstract]   [Full Text] [Related]  

  • 15. Paregoric on prescription.
    Tice LF
    Am J Pharm Sci Support Public Health; 1972; 144(2):39-40. PubMed ID: 5068202
    [No Abstract]   [Full Text] [Related]  

  • 16. Keeping prescription drugs safe and effective.
    Bryan PA
    Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
    [No Abstract]   [Full Text] [Related]  

  • 17. Programs for monitoring inappropriate prescribing of controlled drugs: evaluation and recommendations.
    Collins TM; Zimmerman DR
    Am J Hosp Pharm; 1992 Jul; 49(7):1765-8. PubMed ID: 1621738
    [No Abstract]   [Full Text] [Related]  

  • 18. PADS approach to preventing prescription drug diversion.
    Ambre JJ
    NIDA Res Monogr; 1993; 131():141-4. PubMed ID: 8413524
    [No Abstract]   [Full Text] [Related]  

  • 19. Benefits/risks of syrup of ipecac.
    Mofenson HC; Caraccio TR
    Pediatrics; 1986 Apr; 77(4):551-2. PubMed ID: 2870465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WHO launches taskforce to fight counterfeit drugs.
    Burns W
    Bull World Health Organ; 2006 Sep; 84(9):689-90. PubMed ID: 17128332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.